Data from SURMOUNT-5, a head-to-head trial, demonstrate tirzepatide offered greater weight loss benefits than semaglutide.

ObjectiveMany laboratory studies have shown that tea consumption protected against the development of esophageal cancer (EC). However, in epidemiological stu...

sis for association of coffee intake and esophageal cancer incidence. Eleven studies, including 457,010 participants and 2628 incident cases, were identified. A relative risk (RR, for cohort study) or...